ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-05-05
- IRS object ID
- 202331259349301933
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-05-05T12:36:08-05:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 050409384 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KAHN LITWIN RENZA & CO LTD | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 951 NORTH MAIN STREET | AddressLine1Txt |
| City | PROVIDENCE | CityNm |
| State Abbreviation | RI | StateAbbreviationCd |
| ZIP | 02904 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ALZHEIMER'S DISEASE RESEARCH FOUNDATION | BusinessNameLine1Txt |
| Business Name Line2 | D/B/A CURE ALZHEIMER'S FUND | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ALZH | BusinessNameControlTxt |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TIMOTHY W ARMOUR | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 7812373800 | PhoneNum |
| Signature | 2023-05-05 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | TIMOTHY | PersonFirstNm |
| Person Last | ARMOUR | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | SANDY ROSS | PreparerPersonNm |
| PTIN | P01399337 | PTIN |
| Phone | 4012742001 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Authentication Assurance Level | AAL1 | AuthenticationAssuranceLevelCd |
| Identity Assurance Level | IAL1 | IdentityAssuranceLevelCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CURE ALZHEIMER'S FUND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | TIMOTHY W ARMOUR | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $47,449,763 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | HTTP://CUREALZ.ORG/ | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 7 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 6 | VotingMembersIndependentCnt |
| Total Employee | 33 | TotalEmployeeCnt |
| Total Volunteers | 35 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $26,547,838 | PYContributionsGrantsAmt |
| CY Contributions Grants | $32,354,655 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $32,050 | PYInvestmentIncomeAmt |
| CY Investment Income | $8,359,727 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$7,161 | PYOtherRevenueAmt |
| CY Other Revenue | -$6,137 | CYOtherRevenueAmt |
| PY Total Revenue | $26,572,727 | PYTotalRevenueAmt |
| CY Total Revenue | $40,708,245 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $17,719,354 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $23,431,727 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $3,128,684 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,951,303 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,662,785 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $2,317,237 | PYOtherExpensesAmt |
| CY Other Expenses | $3,229,984 | CYOtherExpensesAmt |
| PY Total Expenses | $23,165,275 | PYTotalExpensesAmt |
| CY Total Expenses | $30,613,014 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $3,407,452 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $10,095,231 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $23,967,152 | TotalAssetsBOYAmt |
| Total Assets EOY | $30,192,784 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $5,766,651 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $1,734,174 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $18,200,501 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $28,458,610 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $24,460,315 | ExpenseAmt |
| Grant | $23,431,727 | GrantAmt |
| Desc | IN 2022, CURE ALZHEIMER'S FUND SUPPORTED 100 RESEARCH PROJECTS AT 59 LEADING RESEARCH INSTITUTIONS, FOR RESEARCH OUTPUT OF MORE THAN $24.4 MILLION. MANY PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT, IN PARTICULAR REGARDING THE ROLE OF THE BRAIN'S INNATE IMMUNE SYSTEM AND THE CONTROL OF THE ENTRY AND EXIT OF MATERIALS FOR HEALTHY BRAIN FUNCTION. ADDITIONAL EXPENSES INCLUDE HUSBANDRY OF TRANSGENIC ANIMAL MODELS BY A CONTRACT RESEARCH ORGANIZATION; THE DIRECT SUPPORT OF FACILITATING GRANTS AND THE AWARD PROCESS; AND COSTS ASSOCIATED WITH ASSESSING RESEARCH PROPOSALS AND DETERMINING FUNDING PRIORITIES. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $3,426,801 | ExpenseAmt |
| Desc | CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $27,887,116 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | Yes (1) | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 30 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 33 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (1) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (1) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 7 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 6 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TIMOTHY W ARMOUR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 7812383800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET STE 310 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| TIMOTHY ARMOUR | ||||||||
| PRESIDENT & CEO | 40.00 | Yes (X) | Yes (X) | $242,641 | $0 | $8,311 | ||
| LAUREL LYLE | ||||||||
| SECRETARY & VP BOARD RELATIONS AND DEVELOPMENT | 30.00 | Yes (X) | Yes (X) | $105,067 | $0 | $3,711 | ||
| HENRY MCCANCE | ||||||||
| CO-CHAIRMAN | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JEFFREY MORBY | ||||||||
| CO-CHAIRMAN | 20.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| PHYLLIS RAPPAPORT | ||||||||
| TREASURER | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| ROBERT GREENHILL | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| JACQUELINE MORBY | ||||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | |||
| SHERRY SHARP TO 1222 | ||||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | |||
| KATHARINE HERMAN | ||||||||
| EVP DEVELOPMENT | 40.00 | $327,432 | $0 | $27,571 | Yes (X) | |||
| BARBARA CHAMBERS | ||||||||
| EVP MARKETING & COMM. | 40.00 | $194,964 | $0 | $18,645 | Yes (X) | |||
| MARGARET SMITH | ||||||||
| EVP, RESEARCH ADMIN | 30.00 | $177,400 | $0 | $21,482 | Yes (X) | |||
| DOUGLAS HARPER | ||||||||
| SENIOR PHILANTHROPIC ADVISOR | 40.00 | $185,943 | $0 | $11,501 | Yes (X) | |||
| LISA RAND | ||||||||
| VP MARKETING & COMM. | 40.00 | $183,812 | $0 | $16,131 | Yes (X) | |||
| JOHN SLATTERY | ||||||||
| SVP MAJOR GIFTS | 40.00 | $179,157 | $0 | $6,339 | Yes (X) | |||
| MAHUA DASGUPTA | ||||||||
| SR. PHILANTROPIC ADVISOR | 40.00 | $161,817 | $0 | $21,937 | Yes (X) | |||
| KELLY WESTERHOUSE | ||||||||
| VP GIVING | 40.00 | $147,868 | $0 | $10,146 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,906,101 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $145,774 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 13 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| PROPER VILLAINS INC | |||||
| 855 BOYLSTON STREET 10TH FLOOR | BOSTON | MA | 02116 | CREATIVE AND PRODUCTION SERVICES | $297,563 |
| GRYPHON CONSULTING INC | |||||
| 21 DEAN ST | BELMONT | MA | 02478 | FINANCIAL & MGT CONSULTANT | $175,283 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $313,024 | FundraisingAmt |
| All Other Contributions | $32,041,631 | AllOtherContributionsAmt |
| Noncash Contributions | $5,919,199 | NoncashContributionsAmt |
| Total Contributions | $32,354,655 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $93,408 | TotalRevenueColumnAmt |
| Exclusion | $93,408 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $14,929,740 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $6,663,421 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $8,266,319 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $8,266,319 | TotalRevenueColumnAmt |
| Exclusion | $8,266,319 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $71,960 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $313,024 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $78,097 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$6,137 | TotalRevenueColumnAmt |
| Exclusion | -$6,137 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $40,708,245 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $8,353,590 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $19,201,841 | TotalAmt |
| Program Services | $19,201,841 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,229,886 | TotalAmt |
| Program Services | $4,229,886 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,127,225 | TotalAmt |
| Program Services | $450,674 | ProgramServicesAmt |
| Management And General | $88,620 | ManagementAndGeneralAmt |
| Fundraising | $587,931 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,381,842 | TotalAmt |
| Program Services | $1,600,832 | ProgramServicesAmt |
| Management And General | $366,697 | ManagementAndGeneralAmt |
| Fundraising | $414,313 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $65,929 | TotalAmt |
| Program Services | $42,857 | ProgramServicesAmt |
| Management And General | $11,117 | ManagementAndGeneralAmt |
| Fundraising | $11,955 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $130,430 | TotalAmt |
| Program Services | $72,783 | ProgramServicesAmt |
| Management And General | $18,273 | ManagementAndGeneralAmt |
| Fundraising | $39,374 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $245,877 | TotalAmt |
| Program Services | $155,536 | ProgramServicesAmt |
| Management And General | $28,738 | ManagementAndGeneralAmt |
| Fundraising | $61,603 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,537 | TotalAmt |
| Program Services | $8,491 | ProgramServicesAmt |
| Management And General | $3,229 | ManagementAndGeneralAmt |
| Fundraising | $3,817 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $149,145 | TotalAmt |
| Management And General | $149,145 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $75,000 | TotalAmt |
| Program Services | $75,000 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,344 | TotalAmt |
| Management And General | $30,344 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $545,564 | TotalAmt |
| Program Services | $166,869 | ProgramServicesAmt |
| Management And General | $190,534 | ManagementAndGeneralAmt |
| Fundraising | $188,161 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $777,562 | TotalAmt |
| Program Services | $777,562 | ProgramServicesAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $245,287 | TotalAmt |
| Program Services | $148,991 | ProgramServicesAmt |
| Management And General | $37,156 | ManagementAndGeneralAmt |
| Fundraising | $59,140 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $89,313 | TotalAmt |
| Program Services | $8,057 | ProgramServicesAmt |
| Management And General | $81,256 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $196,349 | TotalAmt |
| Program Services | $111,388 | ProgramServicesAmt |
| Management And General | $26,933 | ManagementAndGeneralAmt |
| Fundraising | $58,028 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $108,919 | TotalAmt |
| Program Services | $36,940 | ProgramServicesAmt |
| Management And General | $116 | ManagementAndGeneralAmt |
| Fundraising | $71,863 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $250,410 | TotalAmt |
| Program Services | $243,623 | ProgramServicesAmt |
| Fundraising | $6,787 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,907 | TotalAmt |
| Management And General | $3,907 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $23,125 | TotalAmt |
| Program Services | $3,625 | ProgramServicesAmt |
| Management And General | $17,605 | ManagementAndGeneralAmt |
| Fundraising | $1,895 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| RESEARCH LAB EXPENSES | $528,064 | $528,064 | ||
| GIFT PROCESSING FEES | $137,649 | $70 | $137,579 | |
| MISCELLANEOUS | $53,809 | $24,097 | $9,373 | $20,339 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,613,014 | TotalAmt |
| Program Services | $27,887,116 | ProgramServicesAmt |
| Management And General | $1,063,113 | ManagementAndGeneralAmt |
| Fundraising | $1,662,785 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,850,918 | BOYAmt |
| EOY | $2,778,505 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,457,855 | BOYAmt |
| EOY | $7,254,987 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,496,905 | BOYAmt |
| EOY | $1,877,735 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $160,657 | BOYAmt |
| EOY | $218,532 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $54,458 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $51,416 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,949 | BOYAmt |
| EOY | $3,042 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,993,868 | BOYAmt |
| EOY | $17,733,326 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $326,657 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,967,152 | BOYAmt |
| EOY | $30,192,784 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $430,625 | BOYAmt |
| EOY | $129,949 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,103,487 | BOYAmt |
| EOY | $763,585 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $232,539 | BOYAmt |
| EOY | $840,640 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,766,651 | BOYAmt |
| EOY | $1,734,174 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,316,372 | BOYAmt |
| EOY | $26,297,281 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,884,129 | BOYAmt |
| EOY | $2,161,329 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,200,501 | BOYAmt |
| EOY | $28,458,610 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,967,152 | BOYAmt |
| EOY | $30,192,784 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $10,095,231 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $162,878 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $19,798,072 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $30,497,342 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $22,873,948 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $26,576,211 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $32,354,655 | CurrentTaxYearAmt |
| Total | $132,100,228 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $19,798,072 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $30,497,342 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $22,873,948 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $26,576,211 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $32,354,655 | CurrentTaxYearAmt |
| Total | $132,100,228 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $14,939,079 | SubstantialContributorsTotAmt |
| Public Support Total170 | $117,161,149 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $77,320 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $83,306 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $15,472 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,497 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $93,408 | CurrentTaxYearAmt |
| Total | $274,003 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $132,374,231 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $253,982 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.88510 | PublicSupportCY170Pct |
| Public Support PY170 | 0.86760 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | 0 | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $75,000 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | 0 | OtherActivitiesInd |
| Total Lobbying Expenditures | $75,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART II-B, LINE 1: | A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. |
| PART II-B, LINE 1(G) | A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,767 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,767 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $46,691 | OtherCostOrOtherBasisAmt |
| Depreciation | $43,649 | DepreciationAmt |
| Book Value | $3,042 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $3,042 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| ACCRUED PAYROLL AND RELATED | $528,365 |
| LEASE PAYABLE | $312,275 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $840,640 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $40,840,779 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $162,878 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$30,344 | OtherRevenueAmt |
| Revenue Not Reported | $132,534 | RevenueNotReportedAmt |
| Revenue Subtotal | $40,708,245 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $40,708,245 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $30,582,670 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $30,582,670 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $30,344 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $30,344 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $30,613,014 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART X, LINE 2: | THE ORGANIZATION IS EXEMPT FROM INCOME TAXES AS A PUBLIC CHARITY UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. MANAGEMENT BELIEVES THAT THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT STATUS AT BOTH THE STATE AND FEDERAL LEVELS. THE ORGANIZATION ANNUALLY FILES IRS FORM 990 RETURNS OF ORGANIZATIONS EXEMPT FROM INCOME TAX, REPORTING VARIOUS INFORMATION THAT THE IRS USES TO MONITOR THE ACTIVITIES OF TAX-EXEMPT ENTITIES. THESE TAX RETURNS ARE SUBJECT TO REVIEW BY THE TAXING AUTHORITIES, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THEY WERE FILED. THE ORGANIZATION CURRENTLY HAS NO TAX EXAMINATIONS IN PROGRESS. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | INVESTMENT FEES -30,344. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH.LIST 59 _ 3SWHEELER - 03/04/21 10:18AM WORKSHEET SCHEDULE F _ 249550 _ 0 | $3,494,976 |
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH.LIST 64 _ 2SWHEELER - 03/08/22 10:46AM WORKSHEET SCHEDULE F _ 229425 | $658,950 |
| MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 0 | 0 | GRANTS AWARDED | ALZHEIMER'S DISEASE RESEARCH | $75,960 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $4,229,886 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $4,229,886 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (24 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| EUROPE | CIRCUITS: CHARACTERIZING EPIGENETIC BIOMARKERS OF HUMAN COGNITIVE AGING | $252,250 | ACH | $0 |
| EUROPE | PERSONALIZED DISEASE PREDICTION FOR ALZHEIMERS DISEASE USING PROTEOME PROFILING: THE EPIC4AD STUDY | $54,921 | ACH | $0 |
| EUROPE | CELLULAR VULNERABILITY TO AGEING | $230,000 | ACH | $0 |
| EUROPE | SFRP1 AS A THERAPEUTIC TARGET AND DIAGNOSTIC/PROGNOSTIC FACTOR INALZHEIMER'S DISEASE | $172,500 | ACH | $0 |
| EUROPE | NOVEL ENTRY ROUTES FOR THERAPEUTIC BIOLOGICALS TO THE BRAIN | $172,500 | ACH | $0 |
| EUROPE | EXTRACELLULAR ATP IS A KEY FACTOR IN PROMOTING ALZHEIMERS DISEASE NEUROINFLAMMATION | $67,500 | ACH | $0 |
| EUROPE | ADTC: IMPACT OF TAU MUTATIONS AND A ON TAU POST-TRANSLATIONAL MODIFICATIONS AND CONFORMATION | $345,000 | ACH | $0 |
| EUROPE | TURNING UP MITOPHAGY TO BLUNT ALZHEIMER TAU PATHOLOGIES | $201,250 | ACH | $0 |
| NORTH AMERICA | SEX MATTERS: UNDERSTANDING THE INFLUENCE OF SEX AND APOE GENOTYPE ON HIPPOCAMPAL PLASTICITY AND COGNITION | $170,200 | ACH | $0 |
| NORTH AMERICA | COMBINED HORMONE THERAPY AS A NOVEL TREATMENT FOR ALZHEIMERS DISEASE IN THE FACE OF A METABOLIC CHALLENGE: INFLUENCE OF SEX AND GENOTYPE | $201,250 | ACH | $0 |
| EUROPE | USING LONG-READ SEQUENCING TO INVESTIGATE THE MAPT LOCUS AND TRANSCRIPTS IN NEURODEGENERATION | $201,250 | ACH | $0 |
| EUROPE | CSF NEUROINFLAMMATORY SIGNATURE IN ALZHEIMERS DISEASE AND RELATED PROTEOPATHIES | $139,840 | ACH | $0 |
| EUROPE | STRUCTURAL MIMICRY IN MICROBIAL AND ANTIMICROBIAL AMYLOIDS CONNECTED TO NEURODEGENERATIVE DISEASES | $124,800 | ACH | $0 |
| MIDDLE EAST AND NORTH AFRICA | STRUCTURAL MIMICRY IN MICROBIAL AND ANTIMICROBIAL AMYLOIDS CONNECTED TO NEURODEGENERATIVE DISEASES | $75,960 | ACH | $0 |
| EUROPE | CSF NEUROINFLAMMATORY SIGNATURE IN ALZHEIMERS DISEASE AND RELATED PROTEOPATHIES | $40,710 | ACH | $0 |
| EUROPE | PERSONALIZED DISEASE PREDICTION FOR ALZHEIMERS DISEASE USING PROTEOME PROFILING: THE EPIC4AD STUDY | $17,816 | ACH | $0 |
| EUROPE | PERSONALIZED DISEASE PREDICTION FOR ALZHEIMERS DISEASE USING PROTEOME PROFILING: THE EPIC4AD STUDY | $469,160 | ACH | $0 |
| EUROPE | NEUROINFLAMMATION CONTRIBUTIONS TO ALZHEIMERS DISEASE: ROLE OF THE CHOROID PLEXUS | $23,000 | ACH | $0 |
| EUROPE | CHARACTERIZATION OF TAU PATHOLOGY HETEROGENEITY ACROSS THE ALZHEIMERS DISEASE SPECTRUM | $201,250 | ACH | $0 |
| EUROPE | EXTRACELLULAR ATP IS A KEY FACTOR IN PROMOTING ALZHEIMERS DISEASE NEUROINFLAMMATION | $105,000 | ACH | $0 |
| EUROPE | UNDERSTANDING, AND MIMICKING, THE BIOLOGICAL EFFECTS OF THE PLC2 P522R VARIANT THAT PROTECT AGAINST ALZHEIMERS DISEASE | $173,104 | ACH | $0 |
| EUROPE | TARGETING TAUOPATHIES WITH ANTISENSE OLIGONUCLEOTIDES TO SYNAPTOGYRIN-3 | $215,625 | ACH | $0 |
| NORTH AMERICA | APOE CONSORTIUM: EFFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY ON AMYLOID AND CEREBROVASCULAR PATHOLOGIES IN ANIMAL MODELS OF ALZHEIMERS DISEASE | $287,500 | ACH | $0 |
| EUROPE | DEEP MASS SPECTROMETRY PROFILING OF TAU AGGREGATES IN ALZHEIMERS DISEASE AND OTHER TAUOPATHIES | $287,500 | ACH | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROJECT FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A TWO-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROJECT SERVES THE ORGANIZATION'S MISSION TO FUND RESEARCH ACCELERATING BENEFITS TO CURRENT AND POTENTIAL ALZHEIMER'S PATIENTS. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. |
| PART III ACCOUNTING METHOD: |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | FISHER ISLAND GOLF | Event1Nm |
| Gross Receipts Event1 | $384,984 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $313,024 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $71,960 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $58,806 | RentFacilityCostsEvent1Amt |
| Other Direct Expenses Event1 | $19,291 | OtherDirectExpensesEvent1Amt |
| Gross Receipts Total | $384,984 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $313,024 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $71,960 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $58,806 | RentFcltyCostsTotalEventsAmt |
| Oth Direct Expnss Total Events | $19,291 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $78,097 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$6,137 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (85 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|
| UNIVERSITY OF CONNECTICUT | |||||||||
| 263 FARMINGTON AVE | FARMINGTON | CT | 06053 | 060772160 | 501 (C)(3) | $230,000 | $0 | AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE | |
| WASHINGTON UNIVERSITY | |||||||||
| 660 SOUTH EUCLID AVE MSC | ST LOUIS | MO | 63110 | 430653611 | 501 (C)(3) | $252,077 | $0 | APOE: ASSESSING THE ADDED DIAGNOSTIC VALUE OF PERIPHERAL APOE PROTEIN LEVELS IN CURRENT BLOOD-BASED BIOMARKER ASSAYS FOR CNS AMYLOIDOSIS | 8111-29-9000 |
| YALE | |||||||||
| 789 HOWARD AVE PO BOX 208051 | NEW HAVEN | CT | 06520 | 060646973 | 501 (C)(3) | $204,238 | $0 | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMERS DISEASE CHARACTERIZED BY MRI | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $172,500 | $0 | EFFECTS OF DE-PALMITOYLATION AND ACAT INHIBITION ON AXONAL AB GENERATION VIA MAM-ASSOCIATED PALAPP | |
| DUKE | |||||||||
| 210 RESEARCH DRIVE | DURHAM | NC | 27710 | 562247203 | 501 (C)(3) | $194,253 | $0 | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMERS PATHOLOGY IN MICE | |
| MOUNT SINAI | |||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1639 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | ESTABLISHING THE MOLECULAR AND CELLULAR MECHANISMS AND BIOMARKERS OF APOE4-MEDIATED SUSCEPTIBILITY TO TAU-RELATED COGNITIVE IMPAIRMENTS | |
| UNIVERSITY OF VIRGINIA | |||||||||
| PO BOX 400328 | CHARLOTTESVILLE | VA | 22904 | 546001796 | 501 (C)(3) | $198,932 | $0 | TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS | |
| UNIVERSITY OF CALIFORNIA IRVINE | |||||||||
| 3014 GROSS HALL | IRVINE | CA | 92697 | 952226406 | 501 (C)(3) | $250,000 | $0 | NIC: EXAMINING THE ROLE OF HUMAN MICROGLIA IN THE TRANSITION BETWEEN PARENCHYMAL AND VASCULAR BETA-AMYLOID PATHOLOGY | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||||
| 1501 SAN PABLO STREET | LOS ANGELES | CA | 90033 | 951642394 | 501 (C)(3) | $201,250 | $0 | PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN | |
| BRIGHAM AND WOMEN'S | |||||||||
| 60 FENWOOD ROAD | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $287,500 | $0 | APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMERS DISEASE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $172,500 | $0 | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMERS DISEASE | |
| MAYO JACKSONVILLE | |||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $172,500 | $0 | HARNESSING MENINGEAL LYMPHATICS AND IMMUNITY TO ALLEVIATE APOE4-INDUCED BRAIN DYSFUNCTION | |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||||
| 9500 GILMAN DRIVE BSB3092 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $287,500 | $0 | BEE: IDENTIFYING THE BLOOD-BRAIN BARRIER CHANGES DURING ALZHEIMERS DISEASE | |
| HARVARD MEDICAL SCHOOL | |||||||||
| 200 LONGWOOD AVENUE WAB 336 | BOSTON | MA | 02115 | 042103580 | 501 (C)(3) | $250,000 | $0 | NIC: ASSESSING THE LINKS BETWEEN THE MS4A RISK GENES, MICROGLIA, AND ALZHEIMERS DISEASE | |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | |||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | 501 (C)(3) | $230,000 | $0 | RNA AND TAU SEED FORMATION | |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | |||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 752556007 | 501 (C)(3) | $287,000 | $0 | ADTC: THE ROLE OF VCP/P97 IN TAU PRION REPLICATION | |
| YALE | |||||||||
| 310 CEDAR ST BML330A | NEW HAVEN | CT | 06519 | 060646973 | 501 (C)(3) | $172,500 | $0 | ROLE OF MICROGLIAL MATRICELLULAR PROTEIN SPARC IN CONTROL OF INFLAMMASOME ACTIVATION | |
| DUKE | |||||||||
| 3550 HOSPITAL SOUTH | DURHAM | NC | 27710 | 562247203 | 501 (C)(3) | $199,162 | $0 | SEX DIFFERENCES IN ALZHEIMER'S DISEASE PROGRESSION: FRAMINGHAM HEART STUDY | |
| SALK | |||||||||
| 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | 501 (C)(3) | $115,000 | $0 | CIRCUITS: IMPACT OF EPIGENETIC AND CELLULAR VARIANTS ON ALZHEIMERS DISEASE PATHOLOGY | |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||||
| 1300 MORRIS PARK AVENUE VAN ETTEN | BRONX | NY | 10461 | 830621846 | 501 (C)(3) | $100,000 | $0 | APPLICATION OF MACHINE LEARNING METHODS IN ALZHEIMERS DISEASE CLINICAL TRIALS | 3C5B |
| WEILL CORNELL | |||||||||
| 407 E 61ST STREET | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $172,500 | $0 | GUT MICROBIOTA, ENDOTHELIAL DYSFUNCTION AND TAU-MEDIATED COGNITIVE IMPAIRMENT | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||||
| 3715 MCCLINTOCK AVE | LOS ANGELES | CA | 90089 | 951642394 | 501 (C)(3) | $219,535 | $0 | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES | |
| WASHINGTON UNIVERSITY | |||||||||
| 425 SOUTH EUCLID AVE BOX 8111 | ST LOUIS | MO | 63110 | 430653611 | 501 (C)(3) | $172,500 | $0 | TARGETING REACTIVE ASTROCYTES FOR THERAPEUTIC INTERVENTION OF ALZHEIMERS DISEASE | |
| WEILL CORNELL | |||||||||
| 413 EAST 69TH STREET ROOM 920 | NEW YORK | NY | 10021 | 136094042 | 501 (C)(3) | $250,000 | $0 | DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMERS DISEASE | |
| MOUNT SINAI | |||||||||
| ONE GUSTAVE L LEVY PLACE BOX 1137 | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $217,327 | $0 | MICROGLIAL-SPECIFIC INPP5D KNOCKDOWN MODULATES BEHAVIOR, AMYLOIDOSIS, AND TAUOPATHY IN ALZHEIMER'S MOUSE MODELS | |
| UNIVERSITY OF VIRGINIA | |||||||||
| 409 LANE ROAD MR4- 6154 | CHARLOTTESVILLE | VA | 22908 | 546001796 | 501 (C)(3) | $201,250 | $0 | EXPLORING THE THERAPEUTIC POTENTIAL OF CLUSTERIN IN A PRECLINICAL MODEL OF ALZHEIMERS DISEASE | |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||||
| 9500 GILMAN DRIVE DEPT 0651 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $250,000 | $0 | NIC: LEVERAGING ENHANCER LANDSCAPES TO DECODE AD RISK ALLELES IN MICROGLIA | |
| MOUNT SINAI | |||||||||
| ONE GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | SYSTEMS INTEGRATION AND THERAPEUTICS TRANSLATION IN ALZHEIMERS DISEASE | |
| BROAD INSTITUTE | |||||||||
| 415 MAIN STREET | CAMBRIDGE | MA | 02142 | 263428781 | 501 (C)(3) | $171,207 | $0 | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMERS DISEASE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $197,500 | $0 | AD4: MODULATING CD33 FUNCTION AND NEUROINFLAMMATION AS A THERAPEUTIC APPROACH FOR ALZHEIMERS DISEASE | |
| BETH ISRAEL DEACONESS MEDICAL CENTER | |||||||||
| 330 BROOKLINE AVENUE | BOSTON | MA | 02215 | 042103881 | 501 (C)(3) | $248,980 | $0 | CIRCUITS: AUNIFIED APPROACH TO ACTIONABLE ALZHEIMERS DISEASE SIGNATURES | |
| WASHINGTON UNIVERSITY | |||||||||
| 660 SOUTH EUCLID AVE BOX 8111 | ST LOUIS | MO | 63110 | 430653611 | 501 (C)(3) | $345,000 | $0 | APOE CONSORTIUM: ROLE OF APOE ISOFORMS IN IMMUNE RESPONSES IN A MODEL OF TAUOPATHY | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 149 13TH STREET ROOM 2301 | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $287,500 | $0 | NIC: BIOMARKER TOOL DEVELOPMENT IN CAF NEUROIMMUNE CONSORTIUM | |
| HARVARD MEDICAL SCHOOL | |||||||||
| 77 AVENUE LOUIS PASTEUR NRB 1054 | BOSTON | MA | 02115 | 042103580 | 501 (C)(3) | $201,250 | $0 | DISSECTING THE MODULATORY ROLES OF INTERLEUKIN-17 RECEPTOR D IN ALZHEIMER'S DISEASE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $286,595 | $0 | ADTC: HOW DO SOLUBLE TAU SPECIES REPLICATE? | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $250,000 | $0 | CREATION OF A FIBROBLAST/IPS CELL BANK TO FACILITATE PERIPHERAL/BRAIN COMPARISONS, AND ALLOW MOLECULAR INVESTIGATIONS INTO MOLECULAR MECHANISMS UNDERLYING DIFFERENCES IN DISEASE AGGRESSIVENESS | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $172,500 | $0 | REGIONAL VARIABILITY OF PATHOLOGY-ASSOCIATED PROPERTIES OF TAU IN POSTERIOR CORTICAL ATROPHY | |
| WHITEHEAD | |||||||||
| 455 MAIN STREET | CAMBRIDGE | MA | 02142 | 061043412 | 501 (C)(3) | $307,500 | $0 | CIRCUITS: IMPACT OF EPIGENETIC AND CELLULAR VARIANTS ON ALZHEIMERS DISEASE PATHOLOGY | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $172,500 | $0 | DEVELOPMENT OF A MULTICELLULAR BRAIN MODEL TO STUDY BRAIN-VASCULAR-PERIPHERAL IMMUNE CELLS CROSSTALK INALZHEIMERS DISEASE | |
| MAYO JACKSONVILLE | |||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMERS DISEASE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $230,590 | $0 | AD4: HIGH-THROUGHPUT DRUG SCREENING FOR ALZHEIMER'S DISEASE USING 3D HUMAN NEURAL CULTURE SYSTEMS | |
| WASHINGTON UNIVERSITY | |||||||||
| 660 SOUTH EUCLID AVENUE CAMPUS BOX | ST LOUIS | MO | 06311 | 430653611 | 501 (C)(3) | $172,500 | $0 | CONTRIBUTION OF SKULL BONE MARROW-DERIVED CELLS TO ALZHEIMERS DISEASE | 8118 |
| WASHINGTON UNIVERSITY | |||||||||
| 660 SOUTH EUCLID AVENUE MSC | ST LOUIS | MO | 06311 | 430653611 | 501 (C)(3) | $345,000 | $0 | BEE: CROSSTALK OF CNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND ALZHEIMERS DISEASE | 8118-0041-01 |
| BRIGHAM AND WOMEN'S | |||||||||
| 60 FENWOOD ROAD | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $172,500 | $0 | ROLE OF CHECKPOINT MOLECULE TIM-3 IN MICROGLIA REGULATION IN ALZHEIMERS DISEASE | |
| BOSTON CHILDREN'S HOSPITAL | |||||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | 501 (C)(3) | $149,500 | $0 | NEUROINFLAMMATION CONTRIBUTIONS TO ALZHEIMERS DISEASE: ROLE OF THE CHOROID PLEXUS | |
| MSKCC | |||||||||
| 1275 YORK AVE | NEW YORK | NY | 10065 | 131924236 | 501 (C)(3) | $172,500 | $0 | THE ROLE OF IFITM3 AND GAMMA SECRETASE IN MICROGLIA | |
| NEW YORK UNIVERSITY | |||||||||
| 435 EAST 30TH STREET FL 11 | NEW YORK | NY | 10016 | 135562308 | 501 (C)(3) | $174,883 | $0 | THE ROLE OF ASTROCYTE-DERIVED TOXIC LIPIDS MEDIATING DEGENERATION IN ALZHEIMERS DISEASE | |
| NEW YORK UNIVERSITY | |||||||||
| 435 EAST 30TH STREET FL 11 | NEW YORK | NY | 10016 | 135562308 | 501 (C)(3) | $115,000 | $0 | NIC: INVESTIGATION OF AD RISK ALLELES IN ASTROCYTES FOCUS ON CHOLESTEROL TRANSPORT AND MICROGLIA INTERACTIONS | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| MGH EAST 149-2401 13TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $200,417 | $0 | CIRCADIAN PERTURBATIONS OF THE VASCULOME AND MICROGLIOME IN ALZHEIMERS DISEASE | |
| UNIVERSITY OF VIRGINIA | |||||||||
| 409 LANE ROAD MR4-6154 | CHARLOTTESVILLE | VA | 22908 | 546001796 | 501 (C)(3) | $172,500 | $0 | TARGETING A MASTER INNATE IMMUNE ADAPTOR MOLECULE IN ALZHEIMERS DISEASE | |
| WEILL CORNELL | |||||||||
| 1300 YORK AVENUE BOX 63 | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $172,500 | $0 | ROLE OF MICROGLIA IN DEGRADATION AND TRIMMING OF ALZHEIMERS AMYLOID BETA | |
| WASHINGTON UNIVERSITY | |||||||||
| 4488 FOREST PARK AVE SUITE 200 | SAINT LOUIS | MO | 63108 | 430653611 | 501 (C)(3) | $120,015 | $0 | CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM | |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||||
| 9500 GILMAN DRIVE MC 0721 | LA JOLLA | CA | 92093 | 952872494 | 501 (C)(3) | $172,500 | $0 | FUNCTIONAL BASIS FOR NOVEL PKC K56R MUTATION IN ALZHEIMER'S DISEASE | |
| WAKE FOREST | |||||||||
| MEDICAL CENTER BOULEVARD | WINSTONSALEM | NC | 27157 | 223849199 | 501 (C)(3) | $172,500 | $0 | INVESTIGATING THE ROLE OF TAU PROTEIN IN NEURONAL SENESCENCE INDUCTION AND MAINTENANCE | |
| UNIVERSITY OF MICHIGAN | |||||||||
| 2101 COMMONWEALTH BLVD SUITE A AND | ANN ARBOR | MI | 48105 | 386006309 | 501 (C)(3) | $243,407 | $0 | NEUROBIOLOGICAL BASIS OF COGNITIVE IMPAIRMENT IN AFRICAN AMERICANS: DEEP PHENOTYPING OF OLDER AFRICAN AMERICANS AT RISK OF DEMENTIA | D |
| MAYO JACKSONVILLE | |||||||||
| 4500 SAN PABLO ROAD | JACKSONVILLE | FL | 32224 | 593337028 | 501 (C)(3) | $201,250 | $0 | EVALUATING TMEM106B ACCUMULATION IN AD | |
| CARNEGIE MELLON | |||||||||
| 5000 FORBES AVE GHC 7711 | PITTSBURGH | PA | 15213 | 250969449 | 501 (C)(3) | $200,000 | $0 | CIRCUITS: INTERPRETING ALZHEIMERS DISEASE-ASSOCIATED GENETIC VARIATION AT ENHANCER REGIONS | |
| BRIGHAM AND WOMEN'S | |||||||||
| 181 LONGWOOD AVE | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $183,562 | $0 | IMMUNOTHERAPIES TARGETING THE MICROBIOTA TO PREVENT COGNITIVE DECLINE IN ALZHEIMER'S DISEASE | |
| BRIGHAM AND WOMEN'S | |||||||||
| 60 FENWOOD ROAD SUITE 10002J | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $201,250 | $0 | NEUROIMMUNE CONNECTOME PERTURBATIONS IN ALZHEIMERS DISEASE | |
| BARROW | |||||||||
| 240 W THOMAS RD SUITE 403 | PHOENIX | AZ | 08501 | 999999999 | 501 (C)(3) | $170,877 | $0 | HARNESSING BIG DATA TO UNDERSTAND ALZHEIMER'S DISEASE RISK | |
| BOSTON UNIVERSITY | |||||||||
| 72 E CONCORD STREET ROUSSARIE LAB | BOSTON | MA | 02118 | 042103547 | 501 (C)(3) | $167,707 | $0 | APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMERS DISEASE BY APOE | L817 |
| MOUNT SINAI | |||||||||
| 1425 MADISON AVE | NEW YORK | NY | 10029 | 136171197 | 501 (C)(3) | $172,500 | $0 | STRESS AND NEUROVASCULAR-IMMUNE NETWORKS IN ALZHEIMERS DISEASE | |
| NORTHWESTERN | |||||||||
| 303 E SUPERIOR AVE TARRY 7-770 | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $286,357 | $0 | ADTC: THE ROLE OF A-INDUCED MEMBRANE DAMAGE IN TAU PATHOLOGY | |
| WEILL CORNELL | |||||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $287,500 | $0 | BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS | |
| JOHNS HOPKINS | |||||||||
| 725 N WOLFE ST | BALTIMORE | MD | 21205 | 999999999 | 501 (C)(3) | $201,250 | $0 | HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMERS DISEASE PROGRESSION | |
| WEILL CORNELL | |||||||||
| 413 EAST 69TH STREET | NEW YORK | NY | 10065 | 136094042 | 501 (C)(3) | $172,500 | $0 | IDENTIFICATION OF CD33 ANTAGONISTS | |
| UNIVERSITY OF CHICAGO | |||||||||
| 947 EAST 58TH STREET MC0928 | CHICAGO | IL | 60637 | 362177139 | 501 (C)(3) | $210,871 | $0 | IDENTIFYING THE SEX-SPECIFIC ROLES OF THE GUT-MICROBIOME-BRAIN AXIS IN A MOUSE MODEL OF AB AMYLOIDOSIS | |
| UNIVERSITY OF CHICAGO | |||||||||
| 947 EAST 58TH STREET MC0926 | CHICAGO | IL | 60637 | 362177139 | 501 (C)(3) | $229,033 | $0 | TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT | |
| ROCKEFELLER | |||||||||
| 1230 YORK AVE BOX 252 | NEW YORK | NY | 10065 | 131624158 | 501 (C)(3) | $172,500 | $0 | STIMULATING SYNAPTIC PROTEASOME ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE | |
| BOSTON CHILDREN'S HOSPITAL | |||||||||
| BLACKFAN CIRCLE CLS 12257 | BOSTON | MA | 02115 | 042774441 | 501 (C)(3) | $300,000 | $0 | NIC: UNDERSTANDING THE CONSEQUENCES OF NON-CODING AD RISK ALLELES ON MICROGLIA FUNCTION | |
| STONY BROOK | |||||||||
| DEPARTMENT OF COMPUTER SCIENCE ROOM | STONY BROOK | NY | 11794 | 161514621 | 501 (C)(3) | $82,166 | $0 | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMERS DISEASE CHARACTERIZED BY MRI | 137 |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $1,955,000 | $0 | THECUREALZALZHEIMERS GENOME PROJECT | |
| TUFTS | |||||||||
| 136 HARRISON AVENUE ST 328A | BOSTON | MA | 02111 | 042103634 | 501 (C)(3) | $172,500 | $0 | IN VIVO CHARACTERIZATION OF A LOSS OF FUNCTION GGA3 RARE VARIANT ASSOCIATED WITH AD | |
| NORTHWESTERN | |||||||||
| 300 E SUPERIOR ST TARRY 8-711 | CHICAGO | IL | 60611 | 362167817 | 501 (C)(3) | $246,804 | $0 | SINGLE NUCLEUS RNA SEQUENCING ANALYSIS OF ACE1 R1284Q KNOCKIN MICE | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||
| 513 PARNASSUS AVE MSB 1349C | SAN FRANCISCO | CA | 94117 | 946036493 | 501 (C)(3) | $201,250 | $0 | ROLE OF THE CIRCULATING EXERKINE GPLD1 IN AMELIORATING ALZHEIMERS DISEASE PATHOLOGY | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 114 16TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $177,675 | $0 | G2T, AD4 AND GENERAL SCIENTIFIC SUPPORT | |
| BRIGHAM AND WOMEN'S | |||||||||
| 60 FENWOOD ROAD | BOSTON | MA | 02115 | 042312909 | 501 (C)(3) | $201,250 | $0 | TARGETING THE MICROBIOME AND INNATE IMMUNITY IN ALZHEIMERS DISEASE | |
| HOUSTON METHODIST | |||||||||
| 6670 BERTNER AVENUE R6 SOUTH | HOUSTON | TX | 77030 | 760094743 | 501 (C)(3) | $225,000 | $0 | AD4: UNCOVERING THE MOLECULAR MECHANISM OF SELECTED DRUG CANDIDATES DERIVED FROM SYSTEMATICS ALZHEIMERS DRUG REPOSITIONING | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 149 13TH ST | CHARLESTOWN | MA | 02129 | 041564655 | 501 (C)(3) | $172,500 | $0 | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMERS DISEASE | |
| STANFORD | |||||||||
| 290 JANE STANFORD WAY E367 | STANFORD | CA | 94305 | 941156365 | 501 (C)(3) | $172,500 | $0 | A TRANSCRIPTIONAL REJUVENATION SIGNATURE FOR ALZHEIMERS DISEASE | CHEM-H/NEURO BUILDING |
| BOSTON UNIVERSITY | |||||||||
| 72 EAST CONCORD ST L-603 | BOSTON | MA | 02118 | 042103547 | 501 (C)(3) | $197,500 | $0 | AD4: BLOCKING SYNAPTOTOXICITY IN ALZHEIMER'S 3D MODELS | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||
| 513 PARNASSUS AVENUE HSW 1346 | SAN FRANCISCO | CA | 94143 | 946036493 | 501 (C)(3) | $201,250 | $0 | UNDERSTANDING HOW HUMAN BRAIN VASCULAR CELLS MEDIATE GENETIC RISK FOR ALZHEIMER'S DISEASE | |
| WASHINGTON UNIVERSITY | |||||||||
| 660 S EUCLID AVENUE CAMPUS BOX 8103 | ST LOUIS | MO | 63110 | 430653611 | 501 (C)(3) | $172,500 | $0 | NEURONAL SUBTYPE-SPECIFIC MODELING OF ALZHEIMERS DISEASE BY DIRECT NEURONAL REPROGRAMMING OF PATIENT FIBROBLASTS | |
| UNC-CHAPEL HILL | |||||||||
| 4108 MARSICO HALL CAMPUS BOX 7363 | CHAPEL HILL | NC | 27599 | 566001393 | 501 (C)(3) | $172,500 | $0 | SMALL MOLECULE ACTIVATORS OF PLC-Y2 AS NOVEL THERAPEUTICS FOR ALZHEIMERS DISEASE | |
| BAYLOR COLLEGE OF MEDICINE | |||||||||
| ONE BAYLOR PLAZA BCM230 | HOUSTON | TX | 77030 | 741613878 | 501 (C)(3) | $167,637 | $0 | ELUCIDATING THE ROLE OF SOLUBLE EPOXIDE HYDROLASE AND ARACHIDONIC ACID METABOLISM IN NEUROINFLAMMATION AND ALZHEIMERS DISEASE | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 86 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE RESEARCH LEADERSHIP GROUP REVIEWS EACH PROJECT FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S DISEASE. ALL FUNDED RESEARCHERS MAY BE ASKED TO REVIEW OCCASIONAL PROPOSALS ON A TWO-WEEK TIMELINE AS A CONDITION OF RECEIVING FUNDING. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROJECT SERVES THE ORGANIZATION'S MISSION TO FUND RESEARCH ACCELERATING BENEFITS TO CURRENT AND POTENTIAL ALZHEIMER'S PATIENTS. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY REVIEWER MAY RESULT IN A REQUEST FOR ITERATION OR REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTIONS, OR REJECTION BUT WILL NOT RECEIVE ANY "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION IF A PROPOSAL IS FUNDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KATHARINE HERMAN | ||||||||||||||
| EVP DEVELOPMENT | $327,432 | $0 | $0 | $0 | $0 | $0 | $10,128 | $0 | $17,443 | $0 | $355,003 | $0 | $0 | $0 |
| TIMOTHY ARMOUR | ||||||||||||||
| PRESIDENT & CEO | $242,641 | $0 | $0 | $0 | $0 | $0 | $7,351 | $0 | $960 | $0 | $250,952 | $0 | $0 | $0 |
| BARBARA CHAMBERS | ||||||||||||||
| EVP MARKETING & COMM. | $194,964 | $0 | $0 | $0 | $0 | $0 | $6,188 | $0 | $12,457 | $0 | $213,609 | $0 | $0 | $0 |
| LISA RAND | ||||||||||||||
| VP MARKETING & COMM. | $183,812 | $0 | $0 | $0 | $0 | $0 | $5,777 | $0 | $10,354 | $0 | $199,943 | $0 | $0 | $0 |
| MARGARET SMITH | ||||||||||||||
| EVP, RESEARCH ADMIN | $177,400 | $0 | $0 | $0 | $0 | $0 | $5,802 | $0 | $15,680 | $0 | $198,882 | $0 | $0 | $0 |
| DOUGLAS HARPER | ||||||||||||||
| SENIOR PHILANTHROPIC ADVISOR | $185,943 | $0 | $0 | $0 | $0 | $0 | $5,585 | $0 | $5,916 | $0 | $197,444 | $0 | $0 | $0 |
| JOHN SLATTERY | ||||||||||||||
| SVP MAJOR GIFTS | $179,157 | $0 | $0 | $0 | $0 | $0 | $5,457 | $0 | $882 | $0 | $185,496 | $0 | $0 | $0 |
| MAHUA DASGUPTA | ||||||||||||||
| SR. PHILANTROPIC ADVISOR | $161,817 | $0 | $0 | $0 | $0 | $0 | $5,188 | $0 | $16,749 | $0 | $183,754 | $0 | $0 | $0 |
| KELLY WESTERHOUSE | ||||||||||||||
| VP GIVING | $147,868 | $0 | $0 | $0 | $0 | $0 | $4,609 | $0 | $5,537 | $0 | $158,014 | $0 | $0 | $0 |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PROPER VILLIANS INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | A PRINCIPAL OF THE VENDOR IS THE SPOUSE OF A KEY EMPLOYEE | RelationshipDescriptionTxt |
| Transaction | $279,563 | TransactionAmt |
| Transaction | CREATIVE AND PRODUCTION SERVICES | TransactionDesc |
| Sharing Of Revenues | 0 | SharingOfRevenuesInd |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 56 | ContributionCnt |
| Noncash Contributions Rpt F990 | $5,919,199 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | SALE PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (1) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 32B: | FormAndLineReferenceDesc |
| Explanation | WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR SOON THEREAFTER AS IS PRACTICAL THROUGH FIRST REPUBLIC BANK AND BANK OF NEW YORK/MELLON. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY THE EXTERNAL AUDITORS AND REVIEWED BY THE PRESIDENT AND CONTRACT CFO. REVISIONS, CORRECTIONS, ETC. ARE MADE AS NECESSARY. ONCE ALL ARE SATISFIED WITH THE FORM, IT IS FINALIZED AND A COPY IS SENT TO ALL BOARD MEMBERS. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH YEAR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED TO ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES. THESE PEOPLE ARE ASKED TO REVIEW THE POLICY AND SIGN A STATEMENT INDICATING THAT THEY UNDERSTAND THE POLICY AND HAVE REPORTED ALL POTENTIAL CONFLICTS DURING THE PAST YEAR IN ACCORDANCE WITH THE POLICY AND WILL REPORT ALL POTENTIAL CONFLICTS DURING THE COMING YEAR. ALL POTENTIAL CONFLICTS ARE EVALUATED BY THE BOARD TO DETERMINE IF A CONFLICT ACTUALLY EXISTS. IN THOSE INSTANCES WHERE THE POTENTIAL TRANSACTION IS A CONFLICT, THE BOARD EXAMINES THE TRANSACTION AND A VOTE IS TAKEN (WITH THOSE INVOLVED RECUSING THEMSELVES) AS TO WHETHER THE ORGANIZATION WILL ENTER INTO THE TRANSACTION. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYERS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE. |
Comments